Using a combination of siRNA and pharmaceutical regulators, we show that these changes in YAP, IFT88, and MYH10 drive the increased susceptibility to pro-inflammatory cytokines caused by LSS. This evidence concerns the gene MYH10 and Leigh syndrome.